Instituto Sanidad Ganadera, Argentina acquired by Ceva >
New company will build on strong biological expertise and expand Ceva’s platform in South American zone.
Joint Venture agreement between Ceva and Huadu signed in Beijing >
“Ceva Huadu” to become Innovation & R&D platform for biologicals
Dr. Steve Chu joins Ceva after 25 years at Fort Dodge and Elanco >
Addition to talented team positions Ceva for continued growth.
Ceva opens new production facility in Lenexa, Kansas >
May 3, 2011, Lenexa, Kan. –– Ceva Animal Health is pleased to announce the May 3, 2011 opening of a new poultry vaccine production facility at its Biomune Campus in Lenexa, Kansas.
Ceva conducts latest of its Expert Symposia >
Veterinary specialists gather in Madrid to discuss latest trends in sow reproduction
Ceva re-enforces expertise in freeze-drying with completion of € 2.8m plant >
Ceva Santé Animale intends to use the new freeze-drying facility to increase its toll-manufacturing activity.
Ceva finishes first decade of success with strong growth >
2010 results demonstrate global ability to generate sales and earnings
Ceva becomes official partner of Vet2011 >
2011 is World Veterinary year, let’s show pride in our profession “Vet for health, Vet for food, Vet for the planet!”.
Ceva launches latest of its Vector Vaccines at VIV Asia 2011 >
VECTORMUNE HVT- NDV® generates strong interest at symposium organised to present new strategies to combat Newcastle Disease.
Stamp Out Sleeping sickness (S.O.S.) initiative highlighted at WHO 3rd International Conference on Neglected Zoonotic >
At the WHO Third International Conference on Neglected Zoonotic Diseases held on November 23/24 2010, Dr. Anthony Mbonye, the Commissioner of Health Services in Uganda praised the SOS initiative as an excellent example of an “One Health” approach, where experts from the animal, human and public health sectors have worked together to control trypanosomiasis or sleeping sickness.